Cambridge Medical Technologies key facts
- Manufacturer of medical devices designed to obtain regular clinical-grade readings of blood biomarkers.
- Cambridge Medical Technologies’s last known valuation is $88.0M.
- It has raised $28.0M; the latest was Later Stage VC ($18.2M) in Jun 2024.
- Notable investors include 24Haymarket, Cadence Venture Capital, Crimson Phoenix, Kayan Ventures, Massar International — 8 tracked in total.
- Status: Privately Held (backing).
Who backs Cambridge Medical Technologies
8- ·Watch Cambridge Medical Technologies: the Monday email on marks, rounds and moves
Cambridge Medical Technologies funding rounds
No funding rounds for Cambridge Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Cambridge Medical Technologies valuation
Cambridge Medical Technologies's last known valuation is $88 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Cambridge Medical Technologies investors
8 investors are on record for Cambridge Medical Technologies, including 24Haymarket, Cadence Venture Capital, Crimson Phoenix and Kayan Ventures.
About Cambridge Medical Technologies
Manufacturer of medical devices designed to obtain regular clinical-grade readings of blood biomarkers. The company's nano-scale fluid sampling and testing systems electrochemically detect blood analytes present in the interstitial fluid, enabling healthcare providers to make informed decisions and monitor patient progress effectively.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2014
- Employees
- 13
- Website
- cambridgemedtech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Cambridge Medical Technologies’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.